Showing 271-280 of 894 results for "".
Staphylococcus aureus and Atopic Dermatitis: Unweaving a Tangled Web
https://practicaldermatology.com/topics/general-topics/staphylococcus-aureus-and-atopic-dermatitis-unweaving-a-tangled-web/22083/Though the relationship is not fully understood, it points the way to potential treatments.Revisiting Facial Seborrheic Dermatitis: A New Therapeutic Option
https://practicaldermatology.com/topics/general-topics/PD0109_05-php/22892/A popular topical agent offers anti-inflammatory, antibacterial, and sebosuppressive effects that could prove useful for management of seborrheic dermatitis.Warts and All: A Treatment Update for Verruca Vulgaris
https://practicaldermatology.com/topics/general-topics/warts-and-all-a-treatment-update-for-verruca-vulgaris/21451/Teledermatology: The Present State of Dermatology's Future
https://practicaldermatology.com/topics/practice-management/teledermatology-the-present-state-of-dermatologys-future/21439/Hidradenitis Suppurativa: Seeking More Pieces to the Puzzle
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-seeking-more-pieces-to-the-puzzle/23669/Evidence suggests that integrated approaches to care may yield best results for many patients.Getting to the Root of ACD
https://practicaldermatology.com/topics/atopic-dermatitis/getting-to-the-root-of-acd/20356/A practical approach to dermatitis in young and old.Case Report: Treatment of Refractory Pemphigus Foliaceus with Rituximab; Financial Matters; AAD; ASDS Resources
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-treatment-of-refractory-pemphigus-foliaceus-with-rituximab-financial-matters-aad-asds-resources/21033/Real-Life Treatment Strategies: Topical Combination Therapy for Plaque Psoriasis in Patients With Skin of Color
https://practicaldermatology.com/topics/psoriasis/real-life-treatment-strategies-topical-combination-therapy-for-plaque-psoriasis-in-patients-with-skin-of-color/21213/Management of psoriasis among individuals with skin of color will become increasingly important for medical professionals. Here's a review of the distinguishing features of psoriasis in patients with skin of color and their treatment needs.Going Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/going-beyond-staging-for-gene-expression-profiling-in-melanoma-and-cutaneous-squamous-cell-carcinoma/57174/Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.